The Cell Expansion Market size is projected to reach US$ 67.94 billion by 2031 from US$ 18.43 billion in 2023. The market is expected to register a CAGR of 15.60% in 2023–2031. The significantly growing research in drug discovery activities are likely to remain a key cell expansion market trend.
Cell expansion is an important and invariable part of regenerative medicine. On the basis of study and investigation, desired regeneration techniques involve cell expansion procedures to develop the tissue. It helps to understand how to treat injuries and diseases from broken bones to neurodegenerative diseases. Advancements in regenerative medicine industry, and rising demand for cell-based therapies is expected to boost the Cell Expansion market growth over the forecast period.
Cell expansion is an important technology widely utilized in stem cell and regeneration medicine. Cell development has multiple potential applications that include drug testing and development, development of cell-based therapy, cancer tissue research and others. The rising prevalence of chronic diseases cancers, cardiovascular disorders fuel the demand of cell expansion technologies which boosts the growth of the Cell Expansion market.
Cell expansion is a fundamental technology in research and development in regenerative medicine. Regenerative medicine utilizes the current methods and research to revive and replace dead or damaged tissue with the use of stem cells, including embryonic, adult, and induced pluripotent stem cells (iPS). Stem cells have a central role in the generating therapeutic cells and personalized medicine.
Additionally, various initiatives undertaken at the international level to increase the use of stem cells for regenerative medicine contributes to the growth of regenerative medicine industry. Japan and UK initiated a program named the UK-Japan Regenerative Medicine and Stem Cell Research Initiative that aims at providing funding for nearly eight collaborative research projects that build upon fundamental insights and initial early-stage discoveries to advance regenerative approaches towards clinical use in the future and to utilize stem cells as medical research tools.
The emerging markets in the developing countries are creating better opportunities for significant market players to expand their business. Most of the major players focus on emerging markets including India, China, Australia among others owing to large number of chronic diseases such as cancer and growing medical tourism in developing countries. Many of the emerging countries are facilitated with high technology-based research facilities and advanced life science studies.
Key segments that contributed to the derivation of the Cell Expansion market analysis are product, cell type, application, and end user.
The geographic scope of the Cell Expansion market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
In North America, the market is currently in the growth phase and experiencing exponential growth. The rising prevalence of chronic and congenital medical conditions, coupled with the availability of research funding, are expected to fuel the cell expansion market growth. In the US several initiatives in the field of stem cell therapies have been taken. The stem cell gene therapy can be used for treating various chronic and rare disorders. For instance, the stem cell gene therapy developed by UCLA researchers provides a cure for babies born with severe combined immunodeficiency (SCID) associated with adenosine deaminase (ADA) deficiency, which is a rare and life-threatening condition that can prove to be fatal within the first year of life, if left untreated.
The regional trends and factors influencing the Cell Expansion Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Cell Expansion Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 18.43 Billion |
| Market Size by 2031 | US$ 67.94 Billion |
| Global CAGR (2023 - 2031) | 15.60% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Cell Expansion Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Cell Expansion Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Cell Expansion market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
The “Cell Expansion Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas: